↓ Skip to main content

Clinical and Experimental Experience with Factor Xa Inhibitors

Overview of attention for article published in American Journal of Cardiovascular Drugs, September 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

patent
15 patents

Readers on

mendeley
34 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Clinical and Experimental Experience with Factor Xa Inhibitors
Published in
American Journal of Cardiovascular Drugs, September 2012
DOI 10.2165/00129784-200404060-00006
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United Kingdom 1 3%
Chile 1 3%
Unknown 32 94%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Doctoral Student 3 9%
Student > Bachelor 3 9%
Student > Master 3 9%
Researcher 3 9%
Other 2 6%
Other 7 21%
Unknown 13 38%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 14 41%
Nursing and Health Professions 2 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Biochemistry, Genetics and Molecular Biology 1 3%
Engineering 1 3%
Other 0 0%
Unknown 15 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 December 2023.
All research outputs
#8,534,976
of 25,373,627 outputs
Outputs from American Journal of Cardiovascular Drugs
#192
of 467 outputs
Outputs of similar age
#64,140
of 187,194 outputs
Outputs of similar age from American Journal of Cardiovascular Drugs
#46
of 127 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 467 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.7. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 187,194 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 127 others from the same source and published within six weeks on either side of this one. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.